Showing results (111-120 of 731) with videos related to
Sort By:
Pageof 74
Digestive Diseases and Sciences|March 1, 1992
Helicobacter pylori and luminal gastric pH. Relationships in nonulcer dyspepsiaP Bechi, R Dei, A Amorosi, et al.Rinsho Shinkeigaku = Clinical Neurology|January 23, 1999
[Ipsilateral central-type facial palsy and contralateral hemiparesis associated with unilateral medial medullary infarction: a case report]T Yamana, Y Hasegawa, R Dei, et al.Digestive Diseases and Sciences|May 1, 1993
Helicobacter pylori potentiates histamine release from serosal rat mast cells in vitroP Bechi, R Dei, M G Di Bello, et al.Le Infezioni in Medicina|April 23, 2003
[In vitro susceptibility of different erythromycin-resistant phenotypes of Streptococcus pyogenes to moxifloxacin and other fluoroquinolones]S. Novielllo, F. Ianniello, S. Esposito, et al.Antimicrobial Agents and Chemotherapy|November 1, 1988
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosaH C Neu, N X Chin, A NovelliEuropean Journal of Pharmacology|August 3, 1994
Two components in neurotoxicity by L-2-amino-3-phosphonopropionate in cultured cerebellar neuronsA Novelli, A Torreblanca, M T Fernández-SánchezCanada Diseases Weekly Report = Rapport Hebdomadaire Des Maladies Au Canada|September 1, 1990
Excitatory amino acids toxicity in cerebellar granule cells in primary cultureA Novelli, J Kispert, A Reilly, et al.Antimicrobial Agents and Chemotherapy|July 1, 1989
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338H C Neu, A Novelli, N X ChinAntimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesN X Chin, A Novelli, H C NeuJournal of Clinical Pharmacy and Therapeutics|January 8, 2009
Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapyE Cecchi, F Lapi, A Vannacci, et al.Pageof 74